Menu Menu

TERN    Terns Pharmaceuticals Inc    1831363    
Income Statement
Net Income -21,945,000

Balance Sheet
Current Assets 376,506,000
Assets 378,233,000
Current Liabilities 11,412,000
Liabilities 13,763,000
Equity 364,470,000
Shares Out 84,436,000

Cash Flow Statement
Operating Cash Flow -55,432,000
Investing Cash Flow 81,938,000

Market Analysis
Market Cap 837,621,145
Price 4.43
BVPS 4.32
PB 1.04
EPS -1.31
PS 3.77
FCF 26,506,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/14 0.45
Apr May Jun
5/13 -0.30
Jul Aug Sep
8/05 -0.31
Oct Nov Dec
11/12

Find a discrepancy? The most accurate way to find company fundamental data is to view TERN documents filed with the SEC.


TERN Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: